North America Contraceptives Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Contraceptives Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Contraceptives Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Contraceptives Market Regional Analysis

6.2 North America Contraceptives Market Revenue 2019-2028 (US$ Million)

6.3 North America Contraceptives Market Forecast Analysis

7. North America Contraceptives Market Analysis – by Product

7.1 Condoms

7.1.1 Overview
7.1.2 Condoms: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Intrauterine Product

7.2.1 Overview
7.2.2 Intrauterine Product: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Vaginal Rings

7.3.1 Overview
7.3.2 Vaginal Rings: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Implants

7.4.1 Overview
7.4.2 Implants: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.5 Patches

7.5.1 Overview
7.5.2 Patches: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.6 Diaphragms

7.6.1 Overview
7.6.2 Diaphragms: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.7 Emergency Contraceptives

7.7.1 Overview
7.7.2 Emergency Contraceptives: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.8 Sponges

7.8.1 Overview
7.8.2 Sponges: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Contraceptives Market Analysis – by End User

8.1 Home Care

8.1.1 Overview
8.1.2 Home Care: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Hospitals and Clinics

8.2.1 Overview
8.2.2 Hospitals and Clinics: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Contraceptives Market Analysis – by Distribution Channel

9.1 Retail Pharmacy

9.1.1 Overview
9.1.2 Retail Pharmacy: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Online Pharmacy

9.2.1 Overview
9.2.2 Online Pharmacy: North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Hospital Pharmacy

9.3.1 Overview
9.3.2 Hospital Pharmacy : North America Contraceptives Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Contraceptives Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Contraceptives Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Contraceptives Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Contraceptives Market Breakdown, by Product
10.2.1.1.2 US: North America Contraceptives Market Breakdown, by End User
10.2.1.1.3 US: North America Contraceptives Market Breakdown, by Distribution Channel

10.2.1.2 Canada: North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Contraceptives Market Breakdown, by Product
10.2.1.2.2 Canada: North America Contraceptives Market Breakdown, by End User
10.2.1.2.3 Canada: North America Contraceptives Market Breakdown, by Distribution Channel

10.2.1.3 Mexico : North America Contraceptives Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Contraceptives Market Breakdown, by Product
10.2.1.3.2 Mexico : North America Contraceptives Market Breakdown, by End User
10.2.1.3.3 Mexico : North America Contraceptives Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Bayer AG

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Church & Dwight, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 CooperSurgical (Cooper Companies, Inc.)

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Mayer Laboratories, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Medicines360

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Merck & Co., Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Prosan International B.V.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Contraceptives Market

Analysis By Product (Condoms, Intrauterine Product (IUDs), Vaginal Rings, Implants, Patches, Diaphragms, Emergency Contraceptives, Sponges, and Others), End User (Home Care, Hospitals and Clinics), and Distribution Channel (Retail Pharmacy, Online Pharmacy, and Hospital Pharmacy)